Abstract: The present invention relates to an artificial-intelligence-based cancer diagnosis and cancer type prediction method, and, more particularly, to an artificial-intelligence-based cancer diagnosis and cancer type prediction method, which extracts nucleic acids from a biological sample to acquire sequence information, and thus generate vectorized data on the basis of aligned nucleic acid fragments, and then inputs same into a trained artificial intelligence model to analyze a calculated value. Compared with a conventional method, which uses a step of determining the number of chromosomes on the basis of a read count and utilizes each related value as a normalized value, the artificial-intelligence-based cancer diagnosis and cancer type prediction method according to the present invention generates vectorized data to perform an analysis using an AI algorithm, and thus is useful in that similar effects can be exhibited even when read coverage is low.
Type:
Grant
Filed:
November 15, 2021
Date of Patent:
December 10, 2024
Assignees:
GC GENOME CORPORATION, AIMA CO., LTD.
Inventors:
Chang-Seok Ki, Eun Hae Cho, Junnam Lee, Jin Mo Ahn, Joohyuk Sohn, Gun Min Kim, Min Hwan Kim